3 July 2023 - From 2025, a systematic evaluation of clinical studies for new medicinal products and medical devices will be carried out at European level in so-called EU-HTA reports (Joint Clinical Assessments) within the framework of the EU-HTA regulation.
The European consultations (Joint Scientific Consultations) will also start in 2025, which will enable an early exchange between manufacturers, EMA and HTA organisations in Europe.